Page last updated: 2024-09-03

thrombin receptor peptide sfllrnp and cyclic gmp

thrombin receptor peptide sfllrnp has been researched along with cyclic gmp in 1 studies

Compound Research Comparison

Studies
(thrombin receptor peptide sfllrnp)
Trials
(thrombin receptor peptide sfllrnp)
Recent Studies (post-2010)
(thrombin receptor peptide sfllrnp)
Studies
(cyclic gmp)
Trials
(cyclic gmp)
Recent Studies (post-2010) (cyclic gmp)
92102922,3463334,062

Protein Interaction Comparison

ProteinTaxonomythrombin receptor peptide sfllrnp (IC50)cyclic gmp (IC50)
Phosphodiesterase Bos taurus (cattle)0.1
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)2.4
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)2.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lassila, R; Rissanen, A; Syrjälä, M; Turpeinen, A; Vehkavaara, S; Westerbacka, J; Yki-Järvinen, H1

Other Studies

1 other study(ies) available for thrombin receptor peptide sfllrnp and cyclic gmp

ArticleYear
Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesity.
    Arteriosclerosis, thrombosis, and vascular biology, 2002, Volume: 22, Issue:1

    Topics: Adenosine Diphosphate; Adult; Analysis of Variance; Blood Platelets; Body Mass Index; Collagen; Cyclic GMP; Enzyme-Linked Immunosorbent Assay; Epinephrine; Glucose; Glucose Clamp Technique; Hemostasis; Humans; Insulin; Insulin Resistance; Obesity; Peptide Fragments; Platelet Aggregation

2002